Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-22

FDA Approved: TIMOLOL MALEATE — Supplemental Application (Sandoz Inc)

View source ↗

Summary

FDA approved a supplemental application for timolol maleate submitted by Sandoz Inc. This action supplements an existing approval for the ophthalmic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Timolol maleate (Timolol maleate)

Snippet

SUPPL AP for TIMOLOL MALEATE (TIMOLOL MALEATE)